Battery Ventures, Doer Capital, Gil & Co., Google, M13, Pear VC and S32 also participated, Mirendil said. The company builds artificial-intelligence systems intended to make AI-driven research and development more accessible to scientists and engineers working in biology and medical fields.
In section Market Quotes
Mirendil Raises $1 Billion in Series A Funding
A $1 billion Series A round will fund further development of Mirendil’s AI models for biology and medicine. The San Francisco company said Thursday that the financing was led by Kleiner Perkins and Clearlake Capital.
Mirendil said one researcher using AI agents recently pretrained its coding model, Mirendil-Base, in three and a half months, using less than $10 million in computing resources. Another product, Lor, is in private beta. It is designed to have hundreds of agents write code and run experiments for days at a time.
Comments (0)
No comments yet. Be the first!